AquaBounty Technologies (AQB)
(Delayed Data from NSDQ)
$1.68 USD
+0.05 (2.76%)
Updated Jul 26, 2024 03:58 PM ET
After-Market: $1.65 -0.03 (-1.49%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AQB 1.68 +0.05(2.76%)
Will AQB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AQB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AQB
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Revenue Estimates
AQB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
AquaBounty Technologies, Inc. (AQB) Reports Q3 Loss, Lags Revenue Estimates
Other News for AQB
AquaBounty Technologies Ushers in New Leadership Era
David Melbourne jr. named AquaBounty CEO
AquaBounty says Wulf retired as CEO, succeeded by David Melbourne
AquaBounty Technologies: A Hold Rating Amidst Operational Shifts and Financial Uncertainties
AquaBounty price target lowered by $1 at Lake Street, here's why